|
|
Volumn 10, Issue 6, 2015, Pages e40-e43
|
|
Spatial tumor heterogeneity in lung cancer with acquired epidermal growth factor receptor-tyrosine kinase inhibitor resistance: Targeting high-level MET-amplification and EGFR T790M mutation occurring at different sites in the same patient
a
a
b
a
a
a
a
a
b
b
a
a
c
b
b
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFATINIB;
CETUXIMAB;
CISPLATIN;
CRIZOTINIB;
DOCETAXEL;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
ERLOTINIB;
FLUORODEOXYGLUCOSE F 18;
GEMCITABINE;
MERELETINIB;
PEMETREXED;
EGFR PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MET PROTEIN, HUMAN;
SCATTER FACTOR RECEPTOR;
ADULT;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER STAGING;
CASE REPORT;
CAUCASIAN;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DRUG TARGETING;
DYSPNEA;
GENE AMPLIFICATION;
GENE FREQUENCY;
GENE MUTATION;
GENE SEQUENCE;
HUMAN;
LUNG ADENOCARCINOMA;
LUNG CANCER;
MALE;
MIDDLE AGED;
MOLECULARLY TARGETED THERAPY;
NEXT GENERATION SEQUENCING;
PLEURA EFFUSION;
PRIMARY TUMOR;
PRIORITY JOURNAL;
TREATMENT DURATION;
VALIDATION STUDY;
ANTAGONISTS AND INHIBITORS;
DRUG RESISTANCE;
GENETICS;
LUNG NEOPLASMS;
MUTATION;
PATHOLOGY;
TREATMENT OUTCOME;
DRUG RESISTANCE, NEOPLASM;
GENE AMPLIFICATION;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
MUTATION;
PROTO-ONCOGENE PROTEINS C-MET;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
TREATMENT OUTCOME;
|
|
EID: 84938217547
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0000000000000503 Document Type: Article |
|
Times cited : (30)
|
|
References (5)
|
